A federal judge on Monday blocked federal funding for embryonic stem cell research. The decision overrides an executive order signed by President Obama over a year and a half ago, just six weeks after he took office, reversing the Bush administration’s strict policy on embryonic stem cell research.
Dr. George Q. Daley is the director of Stem Cell Transplantation Program at Children’s Hospital Boston and Harvard Stem Cell Institute. He tells us about how the decision will affect his research in the United States. We also hear from Russell Korobkin, professor of law at UCLA and author of "Stem Cell Century. Law and Policy for a Breakthrough Technology," on how the Obama administration and Congress may respond to the ruling.